Comparison of expression systems for the production of human interferon-α2b

Central European Journal of Biology

Volumn 5, Issue 4, 2010, Pages 446-455

  Memari, Hamid Rajabi ^a   Ramanan, Ramakrishnan Nagasundara ^b   Ariff, Arbakariya B ^b  

^a SHAHID CHAMRAN UNIVERSITY OF AHVAZ   (Iran)

^b UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Escherichia coli; Expression platform; Interferon 2b; Transgenic tobacco

Indexed keywords

BACTERIA (MICROORGANISMS); CAULIFLOWER MOSAIC VIRUS; ESCHERICHIA COLI; NICOTIANA; NICOTIANA OBTUSIFOLIA; NICOTIANA TABACUM;

EID: 77954028168     PISSN: 1895104X     EISSN: 16443632     Source Type: Journal    
DOI: 10.2478/s11535-010-0036-y     Document Type: Article

References (43)

1. Chelbi-Alix M. K., Wietzerbin J., Interferon, a growing cytokine family: 50 years of interferon research, Biochimie, 2007, 89, 713-718.
2. Hiscott J., Cantell K., Weissmann C., Differential expression of human interferon genes, Nucl. Acids Res., 1984, 12, 3727-3746.
3. Baron S., Tyring S. K., Fleischmann W. R. Jr, Coppenhaver D. H., Niesel D. W., Klimpel G. R., et al., The interferons: Mechanisms of action and clinical applications, J. Am. Med. Assoc., 1991, 266, 1375-1383.
4. Nagabhushan T. L., Giaquinto A., Interferon a2b: an overview from a regulatory perspective, Regulatory Practice for Biopharmaceutical Production, John Wiley & Sons, NY, USA, 1995.
5. Frommer W. B., Ninnemann O., Heterologous expression of genes in bacterial, fungal, animal, and plant cells, Annu. Rev. Plant. Phys., 1995, 46, 419-444.
6. Goeddel D. V., Systems for heterologous gene expression, Meth. Enzymol., 1990, 185, 3-7.
7. Hodgson J., Expression systems: A user's guide. Emphasis has shifted from the vector construct to the host organism, Bio/Technology, 1993, 11, 887-893.
8. Georgiou G., Expression of proteins in bacteria, in Protein Engineering: Principles and Practice, Wiley Liss, NY, USA, 1996.
9. Brown B. L., Hadley M., Page R., Heterologous high-level E. coli expression, purification and biophysical characterization of the spine-associated RapGAP (SPAR) PDZ domain, Protein Expr. Purif., 2008, 62, 9-14.
10. Jana S., Deb J. K., Strategies for efficient production of heterologous proteins in Escherichia coli, Appl. Microbiol. Biotechnol., 2005, 67, 289-298.
11. Peleg Y., Unger T., Application of high-throughput methodologies to the expression of recombinant proteins in E. coli, Methods Mol. Biol., 2008, 426, 197-208.
12. Makrides S. C., Strategies for achieving high-level expression of genes in Escherichia coli, Microbiol. Rev., 1996, 60, 512-538.
13. Fuh G., Mulkerrin M. G., Bass S., McFarland N., Brochier M., Bourell J. H., et al., The human growth hormone receptor. Secretion from Escherichia coli and disulfide bonding pattern of the extracellular binding domain, J. Biol. Chem., 1990, 265, 3111-3115.
14. Mansell T. J., Fisher A. C., DeLisa M. P., Engineering the protein folding landscape in gram-negative bacteria, Curr. Protein Pept. Sci., 2008, 9, 138-149.
15. Zhao M., Zhang N. H., Recent advances of heterologous gene expression in E. coli, Sheng li ke xue jin zhan [Progress in physiology], 1998, 29, 226-230.
16. Daniell H., Streatfield S. J., Wycoff K., Medical molecular farming: Production of antibodies, biopharmaceuticals and edible vaccines in plants, Trends Plant Sci., 2001, 6, 219-226.
17. Barta A., Sommergruber K., Thompson D., Hartmuth K., Matzke M. A., Matzke A. J. M., The expression of a nopaline synthase - human growth hormone chimaeric gene in transformed tobacco and sunflower callus tissue, Plant Mol. Biol., 1986, 6, 347-357.
18. Basaran P., Rodriguez-Cerezo E., Plant molecular farming: Opportunities and challenges, Crit. Rev. Biotechnol., 2008, 28, 153-172.
19. Fischer R., Stoger E., Schillberg S., Christou P., Twyman R. M., Plant-based production of biopharmaceuticals, Curr. Opin. Plant Biol., 2004, 7, 152-158.
20. Kermode A. R., Plants as factories for production of biopharmaceutical and bioindustrial proteins: Lessons from cell biology, Can. J. Bot., 2006, 84, 679-694.
21. Twyman R. M., Stoger E., Schillberg S., Christou P., Fischer R., Molecular farming in plants: Host systems and expression technology, Trends Biotechnol., 2003, 21, 570-578.
22. Sørensen H. P., Mortensen K. K., Advanced genetic strategies for recombinant protein expression in Escherichia coli, J. Biotechnol., 2005, 115, 113-128.
23. Schumann W., Ferreira L. C. S., Production of recombinant proteins in Escherichia coli, Genet. Mol. Biol., 2004, 27, 442-453.
24. Studier F. W., Protein production by auto-induction in high density shaking cultures, Protein Expr. Purif., 2005, 41, 207-234.
25. Ramanan R. N., Tey B. T., Ling T. C., Ariff A. B., Classification of pressure range based on the characterization of Escherichia coli cell disruption in high pressure homogenizer, Am. J. Biochem. Biotech., 2009, 5, 21-29.
26. Saghai-Maroof M. A., Soliman K. M., Jorgensen R. A., Allard R. W., Ribosomal DNA spacer-length polymorphisms in barley: Mendelian inheritance, chromosomal location, and population dynamics, Proc. Natl. Acad. Sci. USA, 1984, 81, 8014-8018.
27. Rajabi-Memari H., Jalali-Javaran M., Rasaee M. J., Rahbarizadeh F., Forouzandeh-Moghadam M., Esmaili A., Expression and characterization of a recombinant single-domain monoclonal antibody against MUC1 mucin in tobacco plants, Hybridoma, 2006, 25, 209-215.
28. Ma J. K. C., Barros E., Bock R., Christou P., Dale P. J., Dix P. J., et al., Molecular farming for new drugs and vaccines. Current perspectives on the production of pharmaceuticals in transgenic plants, EMBO Rep., 2005, 6, 593-599.
29. Ramessar K., Capell T., Christou P., Molecular pharming in cereal crops, Phytochem. Rev., 2008, 7, 579-592.
30. Food and Drug Administration (FDA), Guidance for Industry. Drugs, Biologics, and Medical Devices Derived from Bioengineered Plants for Use in Humans and Animals, FDA, 2002.
31. European Medicines Agency (EMA), Points to consider on quality aspects of medicinal products containing active substances produced by stable transgene expression in higher plants CPMP/BWP/764/02, EMA, 2002.
32. Srivastava P., Bhattacharaya P., Pandey G., Mukherjee K. J., Overexpression and purification of recombinant human interferon alpha2b in Escherichia coli, Protein Expr. Purif., 2005, 41, 313-322.
33. Sletta H., Tøndervik A., Hakvåg S., Vee Aune T. E., Nedal A., Aune R., et al., The presence of N-terminal secretion signal sequences leads to strong stimulation of the total expression levels of three tested medically important proteins during high-cell-density cultivations of Escherichia coli, Appl. Environ. Microbiol., 2007, 73, 906-912.
34. Mergulhǎo F. J., Monteiro G. A., Analysis of factors affecting the periplasmic production of recombinant proteins in Escherichia coli, J. Microbiol. Biotechnol., 2007, 17, 1236-1241.
35. Helke A., Geisen R. M., Vollmer M., Sprengart M. L., Fuchs E., An unstructured mRNA region and a 5′ hairpin represent important elements of the E. coli translation initiation signal determined by using the bacteriophage T7 gene 1 translation start site, Nucl. Acids Res., 1993, 21, 5705-5711.
36. Zhu Z., Hughes K. W., Huang L., Sun B., Liu C., Li Y., et al., Expression of human alpha-interferon cDNA in transgenic rice plants, Plant Cell, Tissue Organ Cult., 1994, 36, 197-204.
37. Matzke M. A., Matzke A. J. M., Eggleston W. B., Paramutation and transgene silencing: a common response to invasive DNA?, Trends Plant Sci., 1996, 1, 382-388.
38. Koziel M. G., Carozzi N. B., Desai N., Optimizing expression of transgenes with an emphasis on post-transcriptional events, Plant Mol. Biol., 1996, 32, 393-405.
39. Zhang B., Yanh Y. H., Lin Y. M., Rao Q., Zheng G. G., Wu K. F., Expression and production of bioactive human interleukin-18 in transgenic tobacco plants, Biotechnol. Lett., 2003, 25, 1629-1635.
40. Chen T. L., Lin Y. L., Lee Y. L., Yang N. S., Chan M. T., Expression of bioactive human interferon-gamma in transgenic rice cell suspension cultures, Transgenic Res., 2004, 13, 499-510.
41. Ernst S., Garro O. A., Winkler S., Venkatraman G., Langer R., Cooney C. L., Process simulation for recombinant protein production: cost estimation and sensitivity analysis for heparinase I expressed in Escherichia coli, Biotechnol. Bioeng., 1997, 53, 575-582.
42. Foreman L. F., Tobacco 2001 production costs and returns and recent changes that influence costs. Economic Research Service, United States Department of Agriculture, 2003.
43. Evangelista R. L., Kusnadi A. R., Howard J. A., Nikolov Z. L., Process and economic evaluation of the extraction and purification of recombinant β-glucuronidase from transgenic corn, Biotechnol. Prog., 1998, 14, 607-614.